Abstract: Computer-implemented systems and methods implement a unified workflow to capture data representing the usage of both sterile and non-sterile surgical assets. Such capture may be performed within, or at the edge of, the sterile field. Item usage data about both sterile and non-sterile items may be machine-captured, such as by using one or more of a bar code reader, RFID tag reader, and image capture device. The item usage data about both sterile and non-sterile items may be captured and stored into a single data store by a single software application executing on a single computer, and displayed by that software application in a single user interface. A user may provide input to that software application to certify both the sterile and non-sterile item usage data.

Abstract: The invention features methods for preventing platelet activation and aggregation and for treating individuals suffering from conditions or undergoing procedures that may result in unwanted platelet aggregation. The methods are based on the intravenous, subcutaneous, or transdermal administration of a platelet activation or aggregation inhibitor, e.g., xemilofiban, followed by oral administration of the same or a different platelet activation or aggregation inhibitor. The treatment may commence prior to a medical or surgical procedure or after the outbreak of an adverse medical condition, either of which results in the activation of platelets that may lead to thrombus formation, and may continue thereafter.